BIIB

HOLD

Biogen Inc.

Healthcare · Rank #52 · Analyzed Apr 20, 2026

$177.35

Current Price

$562.16

Intrinsic Value

0.0%

Upside/Downside

10/10

Score

3/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score3/5.0

Framework RatingHOLD

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$99.52

Base (IV)$562.16

High$860.04

Entry Points

Conservative$99.52

Moderate$330.84

Aggressive$562.16

⚠️ Warnings

Upside capped: raw 385% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity7.4% → 0/1.0

Debt LevelD/E 36 → 0.5/1.0

Revenue QualityGrowth 2.7%, margin Δ-3.5% +recovery → 1.0/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins13.1% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.